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Whan expressed into Xenopus oocytes. HLK~ K" channel (Kvl-3) induced a slowly inactivating voltage-depend~nt K* current. We have studied 
the modulation of this K" current by co-expressing a cloned 5-HT, receptor together with HLKs K ÷ channel protein, Application of $-HT e, au~d 
a long-lasting inhibition or th~ voltage-gated K* current. This inhibitory modulation was mimicked by intracellular injection of inositol triph~phat= 
or Ca '~, as well as by incubation with phorbol esters or diacylglycerol analogs. Oodles pretreatment with staurosporine and EGTA fully prevented 
5-HT inhibitory action. Elevation of cAMP and cGMP levels into oocyt~s did not produ¢~ any detectable effect on the current recorded in the 
absen~ or th~ presence of 5.HT. The~ data suggest hat the second messengers generated by phospholipase C activation may be important 
modulators of HLK~ K* channels in the immune and the central nervous ystems. 
T cell; Jurkat; Serotonin; Kina~ C; Calcium 
1. INTRODUCTION 
K ÷ channels are ubiquitous membrane proteins 
which are centrally involved in multiple functions in 
both excitable and non-excitable cells [1]. In neurons, 
K + channel diversity influences action potential shaping 
and firing frequency [1,2]. In non-excitable cells, such 
as lymphocytes or glial cells, the expression of a given 
K + channel repertoire seems to be correlated with a 
specific functional stage of the cell development [3,4]. 
The diversity of K + channel electrophysiological prop- 
erties reflects a large set of diverse molecular structures. 
The cloning of several families of voltage-dependent K ÷ 
channel genes in Drosophila, Aplysia, frog and mam- 
mals have been reported (for review see [5,6]). 
By use of probes from Shaker-related K * channels we 
have isolated the gene called HLK3 (corresponding to
Kvl-3 according to the nomenclature proposed by 
Chandy et al. [7]) from a T lymphocyte cell line eDNA 
library [8]. Functional expressien of in vitro synthesized 
RNA of this clone demonstrates that it encodes the so 
called n-type K ~ channel commonly found in human T 
lymphocytes [8]. This K ÷ channel type is also expressed 
in the central nervous ystem [9]. Two genomic lones, 
MK3 and RGKS, corresponding to the mouse and rat 
counterpart ofHLK3, have also been found to direct he 
expression or n-type K* current in Xenopus oocytes 
[10,11]. 
In many neurons and other excitable cells channel 
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modulation by the action of neurotransmitter- or
hormone receptor-activated s cond messenger systems 
has been recognized as an important mechanism which 
adapts cells for particular functions [12-14]. In this re- 
port we investigate the modulation of  HLK3 activity 
expressed in Xeaopus oocytes, either alone or in associ- 
ation with a 5-HT: receptor [15]. 
2, MATERIALS AND METHODS 
Cloning of HLK.~, RNA synth~siso oocyte isolation, inj~tion and 
electrophysiology have been described elsewhere [8,16 I. The Ch in~ 
hamster 5.HT, receptor eDNA clone was isolated by Chambard et al. 
3. RESULTS 
Under voltage-clamp conditions oocytes injected 
with HLK3 cRNA (0.1 ng per oocyte) exhibited out- 
ward K + currents that were activated at membrane po- 
tentials positive to -50 mV, and which were inactivated 
by more than 80% at the end of a 3 s depolarizing pul~ 
(Fig. 1B). The biophysical properties of HLK~ channel 
have been recently described [8]. A cloned Chinese ham- 
ster 5-HT, receptor [15] was co-expressed with HLK~ 
K ~ channel in Xenopus oocytes. In this cell system stim- 
ulation of 5-HT receptors results in G-protein activa- 
tion of phospholipase C [17]. Application of 5-HT (1 
~M) resulted in a profound inhibition of the voltage- 
dependent K + current (Fig. 1A) within 2 rain. The peak 
amplitude of the K* current was decrea~,d maximally 
by 5-HT after about 20 min. No ~ignifieant change in 
the kinetics or the voltage dependence of HLK~ K" 
current was observed following 5-HT application (Fig. 
PublLshed by Elsevier Science Publishers B, E 229 
Volume 303, number 2,3 FEBS LETTERS June 1992 
B (control, , (laA) 




Fig. I. Coexpression of 5-HT., receptor with HLK~ K" channel in 
Xenopus oocytes. (A) Chart recording showing that 5-HT (! ,uM) 
applied for 2 rain reduced the amplitude of the HLK~ K ÷ currents 
recorded uring iterativ¢ depolarizations from a holding potential of 
-80 mV to test potentials of 30 mV, (B) I-V relationships in control 
(e) and 25 rain after the 5.HT application (o), 
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1 B), The inhibitory action was long-lasting and, at I pM 
5-HT, the effect was practically irreversible. 
In oocytes, as in most cells, activated phospholipase 
C generates hasps and diacylglyeerol, resulting in the 
subsequent release of Ca '-+ from intracellular stores and 
activation of  protein kinase C. The involvement of these 
second messengers in mediating the 5-HT inhibition of 
HLK3 K + current was therefore examined, Fig. 2A 
shows that intracellular injection of  GTP?'S, which acti- 
vates phospholipase C via G-proteins, mimicked the 
5.HT-indueed epression of K* currents. Intraeellular 
application of  InsP3 into the oocyte potently inhibited 
K* channel activity, and direct injection of  Ca v' pro- 
duced a similar depression with a time-course close to 
that observed following 5-HT treatment (Fig. 2B,C). 
Prior injection with EGTA slowed the 5-HT inhibition 
onset kinetics by a factor of about two (Fig. 2D). 
The phorbol ester, PMA, and the diacylglycerol ana- 
log, OAG, 'also produced a long-lasting blockade of 
HLK3 K + current (Fig. 3A,B). Interestingly, following 
PMA inhibition a subsequent application of  5-HT fur- 
ther depressed K* channel activity (Fig. 3C). Stauro- 
sporine pretreatment alone did not prevent 5-HT-in- 
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Fig. 2. lntmcellular Ca:" regulates HLK~ channel, (A) lntracdlular 
microinjcetion f GTPyS (final concentration i/zM) depressed HLK~ 
K* current. (B) Intracellular injection of lnsP~ (final concentration I 
~M) inhibited I,ILK~ current. (C) lntracellular injection of Ca:" (final 
concentration 1/aM) inhibited I-ILKs current, (D) Intracellular EGTA 
injection (final concentration 5 raM) delayed the 5-HT (I :tM) inhibi- 
tion. l;.:~iding potential was -80 rnV and test potential 30 inV. 
Fi~, 3. Protein kinase C activation inhibits HLK~ current. (A) 30 nM 
PMA inhibited HLK~ current, (B) 30/~M OAG inhibltgl HLK.~ cur- 
rent, (C) 5-HT (1/aM) inhibition was additive with PMA (30 riM), 
Holding potential was -80 mV and test potential 30 inV. 
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Fig. 4. Phospholipase C products inhibit HLK~ current. (A) Stauro- 
sporin¢ (0,1 #M) pretreatment for 4 h did not reverse the inhibition 
by 5-kiT. (B) Intracellular injection of EGTA (final concentration 5 
raM) and pretreatment with 0.1/~M staurosporin¢ for 4 h reversed the 
5-HT inhibition. Holding potential was -80 mV and test potential 
~o mY. 
dueed inhibition (Fig. 4A), but together with EGTA 
microinjection it completely blocked 5-HT action (Fig. 
4B). The K* current and the action of 5-HT were unaf- 
fected by extracellular pplication of I mM 8-(4-chloro- 
phenylthio)Y,5'-cAMP, I mM 8-Br-cGMP, as well as 
by treatment with the calmodulin antagonists, W7 or 
calmidazolium, and by microinjection with calcineurin 
and alkaline phosphatase. 
We have recently observed [18] that injection into 
ooeytes of different levels of mRNA generates voltage- 
gated K* currents with different biophysical and phar- 
macological properties. On the one hand a low cRNA 
concentration produces an inactivating K + current with 
inwardly-rectifying properties (Fig, 5A). On the other 
hand high levels ofcRNA express a non-inactivating K + 
current that rectifies outwardly (Fig. 5B). To test 
whether different levels of HLK3 expression may influ- 
ence the modulation of channel properties by intracellu- 
lar Ca :+ and by protein kinase C activation we have 
examined the effects of Ca "+ injection, as well as those 
of PMA exposure, to ooeytes injected with two different 
HLK~ ¢RNA concentrations. Our results show that the 
modulation produced by both effectors is not affected 
by the level of mRNA expression (Fig. 5). 
4. DISCUSSION 
This work demonstrates that the human voltage- 
gated K ÷ channel, HLK3 (Kvl-3 [8]), can be depressed 
by activation of a co-expressed 5-HT, receptor. The 
coupling between the receptors and the channel appears 
to be mediated by the inositol phospholipid second mes- 
senger pathway via a G-protein, since activation of this 
pathway evokes a similar modulation. When G-proteins 
are activated by GTPTS, thus bypassing the need for 
receptor stimulation, the K + current was also potently 
C D 
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Fig 5. Regulation of HLK; channel remained constant whatever the 
RNA concentration used. (A) The transient K" curre.nt recorded in 
an oocyte injected with 0.11 ng cRNA was inhibited with 30 nM PMA. 
(B) The sustained K" current recorded in an oocyte injected with 35 
ng cRNA was inhibited with 30 nM PMA. (C) Inhibition by internal 
Ca'* (final concentration I/aM) of the transient current. (D) Inhibition 
by Ca"" of the sustained current, 
blocked, indicating that the 5-HT action is mediated by 
a G-protein. Direct G-protein activation of HLK~ chan- 
nels seems unlikely because direct coupling generally 
occurs within miilis~onds (for a review see [19]). We 
have examined whether phospholipase C products alter 
HLK3 K ÷ currents. Our results indicate that the two 
second messenger products, diacylglyeerol and tnsP3, 
have the potential to converge signalling by inhibiting 
the voltage-gated K" current. Intracellular injection of 
InsP~ or Ca'* shows that an increase in intracellular 
Ca-'* concentration leads to a decreased K" channel 
activity. Recent reports have also observed a similar 
modulation by Ca -'+ of mouse (MBKI) and rat (RBKI) 
delayed rectifier K ÷ channels cloned from brain [20,21]. 
Direct gating of the channel by intracellular Ca:* is 
unlikely since the modulation of K* currents affected by 
free Ca z÷ levels usually occurs in the millisecond range. 
The Ca :+ regulatory action on I-ILK~ K + current may 
involve a change in the phosphorylation state of the 
channel. However, alkaline phosphatase and cal- 
cineurin microinjections did not prevent Ca:" inhibition 
nor 5-HT action. Alternatively, the action of a Ca'-'- 
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activated protease cannot be excluded, Further experi- 
ments are clearly needed to address this problem. 
Our  data show that the modulat ion of  the HLK3 K + 
channel by protein kinase C activation is also inhib- 
itory, In this regard a recent report [22] has shown that 
protein kinase C can phosphorylate a Drosophila 
Shaker K + channel at a site located in the S4-$5 intra- 
cellular loop and which is conserved in the HLKs amino 
acid sequence [8]. The question now is to understand 
how results obtained with the cloned channel relate to 
observations which have been made in studies on the 
regulation of n-type K" channels in lymphocytes. First, 
the potent and long-lasting inhibition of  the cloned volt- 
age-sensitive K"  channel observed in this work in the 
presence of  phorbol esters and diacylglycerol has not 
been described for human circulating T-]ymphocytes 
[23], as if subunits other than the HLK3 subunit pre- 
vented phosphorylation and inhibition by kinase C (for 
example K + channels also have fl subunits [24]). Second, 
the lack of  a cAMP effect observed in this work is 
consistent with the absence o f  cAMP-mediated inhibi- 
tion of  n-type K + currents in haman T cells [25,26], 
although a partial inhibition (due to an acceleration of  
inactivation) of  probably similar K* channels has been 
observed in B lymphocytes [27]). Finally, the inhibitory 
effect of  intracellular Ca 2+ on the cloned HLK3 channel 
expression in oocytes is very similar to that found for 
the n-type K" current in T-lymphocytes [25]. 
Lymphocytes bear receptors for a variety of transmit- 
ters that influence cellular functions [28]. Whether the 
opening of  n-type K + channels is crucial for T-cell acti- 
vation still remains unsolved [8,29]. The modulation of  
K* fluxes by several agents, including 5-HT [27], iso- 
proterenol [30,31] and substance P [32], have been re- 
garded as an important pathway for neural regulation 
of  immune function. Knowledge of the action of  diverse 
transmitters on individual cloned channels will certainly 
help to clarify this issue. Similarly, the regulation of  
HLK3 K + channels in the central nervous ystem might 
be of  great significance. Second messengers uch as 
InsP~ and diacylglycerol, by depressing the amplitude of 
this K"  current, could serve to increase action potential 
duration and to decrease neuronal firing frequency. 
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